Skip to main content
Sign In

Getting to the Root of Leukemia

Chemotherapy and bone marrow transplant are the standard-of-care for AML. Now the basic science from Jordan’s lab and the results from clinical trials in Pollyea’s and Smith’s patients are leading to a new paradigm for the treatment of AML.

Pollyea and Pietras earn endowed chairs

Cancer Center announces two newly endowed chairs: Daniel Pollyea, MD, recipient of the Robert H. Allen Endowed Chair in Hematology Research, and Eric Pietras, PhD, recipient of the Ceo Meador/George Ryland Scott Endowed Chair in Hematology Research.

91 percent response rate for venetoclax

Clinical trial results published in the journal Nature Medicine show 91 percent response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML).

Cancer hijacks the microbiome to glut itself on glucose

Cancer gets energy in the form of glucose. But how does it get this glucose? A recent study shows that leukemia undercuts the ability of normal cells to consume glucose, leaving more glucose available to feed its own growth.


Contact Info

General Hematology

Phone: 720.848.0300
1665 Aurora Court
Mailstop F-754
Aurora, CO 80045 

Blood Cancer & BMT

Phone: 720.848.6400
1665 Aurora Court
Mailstop F-754
Aurora, CO 80045 

Referring Providers

DocLine: 720-848-2828

Maps & Directions

 Su   Mo   Tu   We   Th   Fr   Sa 
     1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30


Grand Rounds are on Tuesdays. Hover over the date for quick details. 

You can also see the​ full Calendar​



  • Largest collection of blood disease experts in the Rockies.
  • Outstanding and compassionate care, the latest in new treatments, and cutting edge research.
  • We treat blood cancers such as leukemia, lymphoma, myeloma, myelodysplastic syndrome (MDS), and other blood problems such as anemia (including sickle cell disease), bleeding disorders (including hemophilia), and clotting disorders.
  • ...Read More.